ACE and type 2 diabetes mellitus: Similarly, in a longitudinal study [8] including a cohort of 600 hypertensive T2DM patients with normal levels of albuminuria at baseline, a GFR reduction by 10% or more within a period of 6 months with angiotensin converting enzyme (ACE)-inhibitors was associated with a significantly slower GFR decline over 4 years.